Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Achieve Life Sciences Inc (NASDAQ:ACHV)

2.35
Delayed Data
As of 3:59pm ET
 -0.01 / -0.42%
Today’s Change
2.19
Today|||52-Week Range
10.18
-57.26%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$6.5M

Company Description

Achieve Life Sciences, Inc. is a pharmaceutical company which develops treatment option to help people battling nicotine addiction. It offers Cytisine, which is a plant-based alkaloid with a binding affinity to the nicotinic acetylcholine receptor. Its activities also include research and development, raising capital, building management team, and seeking additional patent approvals. The company was founded on May 12, 2015 and is headquartered in Bothell, WA.

Contact Information

Achieve Life Sciences, Inc.
19820 North Creek Parkway
Bothell Washington 98011
P:(425) 686-1500
Investor Relations:

Employees

Shareholders

Other institutional2.11%
Mutual fund holders1.25%
Individual stakeholders0.33%

Top Executives

Richard A. B. StewartChairman & Chief Executive Officer
Anthony John ClarkePresident, Director & Chief Scientific Officer
John A. BencichChief Financial & Operating Officer, EVP
Cindy A. JacobsChief Medical Officer & Executive Vice President